Cargando…
Refining the DC-targeting vaccination for preventing emerging infectious diseases
The development of safe, long-term, effective vaccines is still a challenge for many infectious diseases. Thus, the search of new vaccine strategies and production platforms that allow rapidly and effectively responding against emerging or reemerging pathogens has become a priority in the last years...
Autores principales: | Pastor, Yadira, Ghazzaui, Nour, Hammoudi, Adele, Centlivre, Mireille, Cardinaud, Sylvain, Levy, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396646/ https://www.ncbi.nlm.nih.gov/pubmed/36016929 http://dx.doi.org/10.3389/fimmu.2022.949779 |
Ejemplares similares
-
DC Subsets Regulate Humoral Immune Responses by Supporting the Differentiation of Distinct Tfh Cells
por: Bouteau, Aurélie, et al.
Publicado: (2019) -
Mouse Models of c-myc Deregulation Driven by IgH Locus Enhancers as Models of B-Cell Lymphomagenesis
por: Ferrad, Melissa, et al.
Publicado: (2020) -
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
por: Alexandre, Marie, et al.
Publicado: (2022) -
Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
por: Noubade, Rajkumar, et al.
Publicado: (2019) -
Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines
por: Ceglia, Valentina, et al.
Publicado: (2022)